Berlin, 1^st July, 2022

Wolf-Medizintechnik GmbH (“WOmed”) now becomes a part of BEBIG Medical to further expand its product portforlio in radiation therapy for cancer treatment.

WOmed, a Germany based company, is a global veteran supplier of cutting edge X-ray therapy and newly developed intraoperative radiation therapy products.

BEBIG Medical is a global provider of high dose rate brachytherapy products with outstanding reputation in radiation therapy industry.

Mr. George Chan, the managing director of BEBIG Medical said, “BEBIG Medical’s main objective is to be the global key supplier for radiation therapy products. This acquisition further expands our product portfolio with a series of X-ray therapy devices for treatment of superficial skin tumors and joint disease as well as a newly developed intraoperative radiation therapy device for breast cancer treatment. Both BEBIG Medical and WOmed will be able to leverage on each other’s good qualities including but not limited to first class manufacturing skillsets and a comprehensive go-to market network. We are all excited to welcome WOmed into the BEBIG Medical family.”